ALRN (Aileron Therapeutics, Inc.) Koefisien nilai perusahaan marang pendapatan

Simbol resmi perusahaan Aileron Therapeutics (ALRN)

Aileron Therapeutics (ALRN) is developing innovative tissue protection agents for cancer therapy based on unique protein inhibition. The EV/Sales trend reflects the market's reaction to asset risk, where the 0.00 mark serves as the current indicator. The monetization of peptide platforms is building long-term capital, while orphan drug status within a narrow oncological niche minimizes competitive pressure.

Aileron Therapeutics Inc (ALRN): Multiplikator EV/Sales saka 23.11.2025 nganti 20.11.2026

Rincian metrik keuangan lan pasar Aileron (ALRN)

- indikator valuasi pasar bisnis:
- data saldo dhuwit lan arus kas:
Pambiji fundamental perusahaan:Aileron Therapeutics Inc ALRN
Sampel barang Aileron Therapeutics Inc

The robotization of laboratory oncology tests accelerates peptide discovery, directly impacting the revenue scaling potential of Aileron Therapeutics (ALRN). By analyzing EV/Sales dynamics, an investor assesses the total enterprise value relative to sales volumes, which allows for the tracking of multiple compression under the pressure of inflationary costs and the timely adjustment of the asset's portfolio weight.